{"id":4579,"date":"2021-08-31T09:10:00","date_gmt":"2021-08-31T09:10:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\/"},"modified":"2021-08-31T09:10:00","modified_gmt":"2021-08-31T09:10:00","slug":"nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\/","title":{"rendered":"Nanexas chef f\u00f6r farmaceutisk utveckling Jonas Fransson har hastigt avlidit"},"content":{"rendered":"
\n

\u201dDet \u00e4r med stor sorg som vi meddelar detta djupt tragiska och h\u00f6gst ov\u00e4ntade besked. Jonas Fransson har efter en kort tids sjukdom hastigt och ov\u00e4ntat l\u00e4mnat oss. V\u00e5ra tankar g\u00e5r till Jonas familj och n\u00e4rmaste\u201d, s\u00e4ger David Westberg, vd f\u00f6r Nanexa.<\/strong><\/p>\n<\/div>\n

\n

Jonas Fransson hade l\u00e5ng och gedigen erfarenhet inom l\u00e4kemedelsutveckling och tilltr\u00e4dde sin tj\u00e4nst i Nanexa den 1 maj i \u00e5r. Han var disputerad apotekare fr\u00e5n Uppsala universitet och hade en l\u00e5ng karri\u00e4r inom l\u00e4kemedelsutveckling fr\u00e5n k\u00e4nda svenska och globala l\u00e4kemedelsbolag. Dessutom f\u00f6rfattade han ett antal vetenskapliga artiklar och stod bakom ett antal patent.<\/p>\n

\u201dJonas har med sin positiva och gener\u00f6sa personlighet och sitt genuina engagemang varit en stark kraft under sin korta tid p\u00e5 Nanexa. Jonas var ocks\u00e5 en mycket omtyckt kollega inom hela det svenska drug delivery-n\u00e4tverket. Vi \u00e4r v\u00e4ldigt tacksamma f\u00f6r den tid vi haft med honom som kollega\u201d, s\u00e4ger David Westberg.
\u00a0<\/p>\n<\/div>\n

\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n

\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Erik Penser Bank \u00e4r bolagets Certified Adviser och n\u00e5s p\u00e5 08-463 83 00, e-post: certifiedadviser@penser.se<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n

\n

Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag fokuserat p\u00e5 utvecklingen av PharmaShell\u00ae, ett nytt och banbrytande drug delivery-system med stor\u00a0potential inom ett flertal substanstyper och indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae utvecklar Nanexa egna projekt och har samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland\u00a0AstraZeneca.<\/p>\n

Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Nanexas chef f\u00f6r farmaceutisk utveckling Jonas Fransson har hastigt avlidit<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\u201dDet \u00e4r med stor sorg som vi meddelar detta djupt tragiska och h\u00f6gst ov\u00e4ntade besked. Jonas Fransson har efter en kort tids sjukdom hastigt och ov\u00e4ntat l\u00e4mnat oss. V\u00e5ra tankar g\u00e5r till Jonas familj och n\u00e4rmaste\u201d, s\u00e4ger David Westberg, vd f\u00f6r Nanexa.<\/p>\n","protected":false},"template":"","class_list":["post-4579","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-listing_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-staff_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nNanexas chef f\u00f6r farmaceutisk utveckling Jonas Fransson har hastigt avlidit - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexas chef f\u00f6r farmaceutisk utveckling Jonas Fransson har hastigt avlidit - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"\u201dDet \u00e4r med stor sorg som vi meddelar detta djupt tragiska och h\u00f6gst ov\u00e4ntade besked. Jonas Fransson har efter en kort tids sjukdom hastigt och ov\u00e4ntat l\u00e4mnat oss. V\u00e5ra tankar g\u00e5r till Jonas familj och n\u00e4rmaste\u201d, s\u00e4ger David Westberg, vd f\u00f6r Nanexa.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\\\/\",\"name\":\"Nanexas chef f\u00f6r farmaceutisk utveckling Jonas Fransson har hastigt avlidit - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2021-08-31T09:10:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexas chef f\u00f6r farmaceutisk utveckling Jonas Fransson har hastigt avlidit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexas chef f\u00f6r farmaceutisk utveckling Jonas Fransson har hastigt avlidit - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexas chef f\u00f6r farmaceutisk utveckling Jonas Fransson har hastigt avlidit - Nanexa AB","og_description":"\u201dDet \u00e4r med stor sorg som vi meddelar detta djupt tragiska och h\u00f6gst ov\u00e4ntade besked. Jonas Fransson har efter en kort tids sjukdom hastigt och ov\u00e4ntat l\u00e4mnat oss. V\u00e5ra tankar g\u00e5r till Jonas familj och n\u00e4rmaste\u201d, s\u00e4ger David Westberg, vd f\u00f6r Nanexa.","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\/","name":"Nanexas chef f\u00f6r farmaceutisk utveckling Jonas Fransson har hastigt avlidit - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2021-08-31T09:10:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexas-chef-for-farmaceutisk-utveckling-jonas-fransson-har-hastigt-avlidit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexas chef f\u00f6r farmaceutisk utveckling Jonas Fransson har hastigt avlidit"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/4579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=4579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}